Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

Human adrenoreceptor polymorphisms: evolving recognition of clinical importance

Article Abstract:

A review was conducted on studies concerning the assessment of adrenoreceptor polymorphisms in human subjects. One study analyzed the entire coding sequence of alpha 1B-adrenoreceptor and identified three various silent polymorphisms. Another examined the relationship between beta 2-adrenoreceptor polymorphisms and the development of asthma and hypertension. It was emphasized that polymorphisms in adrenoreceptors might represent only one type of genetic variation in adrenoreceptor signalling that could impact on the expression of a disease phenotype.

Author: Insel, Paul A., Buscher, Rainer, Herrmann, Volker
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1999
Hypertension, Genetic aspects, Asthma, Genetic polymorphisms

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


On criteria for functional beta3-adrenoreceptors

Article Abstract:

Atypical low stereoselectivity is not a suitable criterion for the classification of beta3-adrenoreceptors due its inconsistency. The stereoselectivity of beta3-adrenoreceptor ligands is a function of ligand affinity hence its unsuitability as a criterion for beta3- adrenoreceptor classification. An additional classification criterion, blockade by beta3-adrenoreceptor-selective antagonists, can be used to increase accuracy.

Author: Kaumann, Alberto J., Molenaar, Peter
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1997
Evaluation, Ligand binding (Biochemistry)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Schwartz and Rosenkilde reply

Article Abstract:

Philip G. Strange's assertion about the role of hydrogen-binding in the binding of adrenoceptors is correct. His claim that the paradigm of adrenoceptor binding is misleading is also correct. Given the absence of methodologies for studying such a physiological process, however, it is virtually impossible to determine and characterize the precise location and mechanics of adrenoceptor binding.

Author: Schwartz, T.M., Rosenkilde, M.M.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1996
DNA-ligand interactions, DNA binding

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Epinephrine, Adrenergic receptors
Similar abstracts:
  • Abstracts: Association of beta3-adrenoceptor polymorphism with obesity and diabetes: current status. Strosberg et al. reply
  • Abstracts: A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. An insight into arterial thrombosis?
  • Abstracts: Multiple P2 receptor subtypes on platelets: a new interpretation of their function. Endogenous ligands and inverse agonism
  • Abstracts: 5-HT4 receptor agonists and bladder disorders. Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoning
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.